Systematic review: Are probiotics useful in controlling gastric colonization by Helicobacter pylori?

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 8, 2006, Pages 1077-1086

  Gotteland, M ^a   Brunser, O ^a   Cruchet, S ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; AMOXICILLIN; ANTIBIOTIC AGENT; ATCC 55730; BACTERIOCIN; CARBOHYDRATE; CLARITHROMYCIN; CRANBERRY EXTRACT; ESOMEPRAZOLE; GARLIC EXTRACT; GLYCOPROTEIN; LACTICIN A164; LACTICIN BH5; LACTOFERRIN; LANSOPRAZOLE; OLL 2716; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROBIOTIC AGENT; PROSTAGLANDIN E2; PROTON PUMP INHIBITOR; R 0011; R 0052; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; RESVERATROL; SHORT CHAIN FATTY ACID; TINIDAZOLE; UNCLASSIFIED DRUG; UREA; WB 1004; YOGHURT;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BERRY; BIFIDOBACTERIUM; BLOATING; CARBOHYDRATE METABOLISM; CRANBERRY; DIARRHEA; DRUG INHIBITION; DRUG SENSITIVITY; DYSPEPSIA; ERADICATION THERAPY; ESCHERICHIA COLI; GARLIC; GRAM NEGATIVE BACTERIUM; GRAPEFRUIT JUICE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SACCHAROMYCES; SACCHAROMYCES BOULARDII; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER; SYSTEMATIC REVIEW; TASTE DISORDER; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST;

ANTI-BACTERIAL AGENTS; BIFIDOBACTERIUM; COMBINED MODALITY THERAPY; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOTHERAPY; LACTOBACILLUS; PHYTOTHERAPY; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; VACCINIUM MACROCARPON;

EID: 33646890232     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02868.x     Document Type: Review

References (66)

1. Marshall BJ Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984 8390 : 1311 5.
2. Taylor DN Parsonnet J. The epidemiology and natural history of Helicobacter pylori infection. In : Blaser MJ Smith PD Ravdin JI Greenberg HB Guerrant RL, eds. Infections of the Gastrointestinal Tract. New York : Raven Press, 1995 : 551 64.
3. Marshall BJ Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am 2005 89 : 313 44.
4. Perez-Perez GI Rothenbacher D Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter 2004 9 Suppl. 1 1 6.
5. Vera JF Gotteland M Chavez E, et al. Sucrose permeability in children with gastric damage and Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 1997 24 : 506 11.
6. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005 21 : 32 8.
7. Gotteland M Corvalan A Sarmiento F, et al. Gastric permeability is not increased in children colonized by CagA-positive strains of Helicobacter pylori. Dig Liver Dis 2001 33 : 750 4.
8. Marteau P Minekus M Havenaar R Huis in't Veld JH. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci 1997 80 : 1031 7.
9. Conway PL Gorbach SL Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987 70 : 1 12.
10. Sherman LA Savage DC. Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium. Appl Environ Microbiol 1986 52 : 302 4.
11. Valeur N Engel P Carbajal N Connolly N Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004 70 : 1176 81.
12. Elliott SN Buret A McKnight W Miller MJ Wallace JL. Bacteria rapidly colonize and modulate healing of gastric ulcers in rats. Am J Physiol 1998 275 Pt 1 G425 32.
13. Alsahli M Michetti P. Lactobacilli for the management of Helicobacter pylori. Nutrition 2001 17 : 268 9.
14. Garrido D Suau A Pochart P Cruchet S Gotteland M. Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. FEMS Microbiol Lett 2005 248 : 249 56.
15. Servin AL Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 2003 17 : 741 54.
16. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005 21 : 44 50.
17. Salminen S Isolauri E Salminen E. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996 70 : 347 58.
18. Ling WH Korpela R Mykkanen H Salminen S Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994 124 : 18 23.
19. Marteau P Flourie B Pochart P Chastang C Desjeux JF Rambaud JC. Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans. Br J Nutr 1990 64 : 71 9.
20. Bhatia SJ Kochar N Abraham P Nair NG Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989 27 : 2328 30.
21. Midolo PD Lambert JR Hull R Luo F Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995 79 : 475 9.
22. Aiba Y Suzuki N Kabir AM Takagi A Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic model. Am J Gastroenterol 1998 93 : 2097 101.
23. Sgouras D Maragkoudakis P Petraki K, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004 70 : 518 26.
24. Oh Y Osato MS Han X Bennett G Hong WK. Folk yoghurt kills Helicobacter pylori. J Appl Microbiol 2002 93 : 1083 8.
25. Tsai CC Huang LF Lin CC Tsen HY. Antagonistic activity against Helicobacter pylori infection in vitro by a strain of Enterococcus faecium TM39. Int J Food Microbiol 2004 96 : 1 12.
26. Pinchuk IV Bressollier P Verneuil B, et al. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 2001 45 : 3156 61.
27. Collado MC Gonzalez A Gonzalez R Hernandez M Ferrus MA Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents 2005 25 : 385 91.
28. Kim TS Hur JW Yu MA, et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 2003 66 : 3 12.
29. Lorca GL Wadstrom T Valdez GF Ljungh A. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 2001 42 : 39 44.
30. Michetti P Dorta G Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999 60 : 203 9.
31. Dalmau M Maier E Mulet N Vinas M Benz R. Bacterial membrane injuries induced by lactacin F and nisin. Int Microbiol 2002 5 : 73 80.
32. Coconnier MH Lievin V Hemery E Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998 64 : 4573 80.
33. Kabir AM Aiba Y Takagi A Kamiya S Miwa T Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997 41 : 49 55.
34. Johnson-Henry KC Mitchell DJ Avistzur Y Galindo-Mata E Jones NL Sherman PM. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 2004 49 : 1095 102.
35. Ushiyama A Tanaka K Aiba Y, et al. Lactobacillus gasseri OLL2716 as a probiotic in clarythromycin-resistant Helicobacter pylori infection. J Gastroenterol Hepatol 2003 18 : 986 91.
36. Uchida M Kurakazu K. Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against acute gastric lesion and antral ulcer in rats. J Pharmacol Sci 2004 96 : 84 90.
37. Nagaoka M Hasimoto S Watanabe T Yokokura T Mori Y. Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides. Biol Pharm Bull 1994 17 : 1012 7.
38. Gotteland M Cruchet S Verbeke S. Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indomethacin in humans. Aliment Pharmacol Ther 2001 15 : 11 7.
39. Mack DR Michail S Wei S McDougall L Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999 276 : G941 50.
40. Songisepp E Kullisaar T Hutt P, et al. A new probiotic cheese with antioxidative and antimicrobial activity. J Dairy Sci 2004 87 : 2017 23.
41. Hamilton-Miller JMT. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2003 22 : 360 6.
42. Canducci F Armuzzi A Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000 14 : 1625 9.
43. Armuzzi A Cremonini F Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001 63 : 1 7.
44. Sheu BS Wu JJ Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002 16 : 1669 75.
45. Cremonini F Di Caro S Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002 97 : 2744 9.
46. Felley CP Corthesy-Theulaz I Rivero JL, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001 13 : 25 9.
47. Tursi A Brandimarte G Giorgetti GM Modeo ME. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 2004 10 : CR662 6.
48. Cruchet S Obregon MC Salazar G Diaz E Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003 19 : 716 21.
49. Gotteland M Cruchet S. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother 2003 51 : 1317 9.
50. Pantoflickova D Corthesy-Theulaz I Dorta G, et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Aliment Pharmacol Ther 2003 18 : 805 13
51. Wang K-J Li S-L Liu C-S, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004 80 : 737 41.
52. Gotteland M Poliak L Cruchet S Brunser O. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus in children colonised by Helicobacter pylori. Acta Paediatr 2005 94 : 1747 51.
53. Wendakoon CN Thomson ABR Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori. Digestion 2002 65 : 16 20.
54. Cats A Kuipers EJ Boschaert MA Pot RG Vandenbroucke-Grauls CM Custers JG. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 2003 17 : 429 35.
55. Sakamoto I Igarashi M Kimura K Takagi A Miwa T Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001 47 : 709 10.
56. Shimizu T Haruna H Hisada K Yamashiro Y. Effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children. J Antimicrobial Chemother 2002 50 : 617 8.
57. Daroch F Hoeneisen M Gonzalez CL, et al. In vitro antibacterial activity of Chilean red wines against Helicobacter pylori. Microbios 2001 104 : 79 85.
58. Limuro M Shibata H Kawamori T, et al. Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 2002 187 : 61 8.
59. Burger O Weiss E Sharon N Tabak M Neeman I Ofek I. Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular weight constituent of cranberry juice. Crit Rev Food Sci Nutr 2002 42 Suppl. 279 84.
60. Lengsfeld C Deters A Faller G Hensel A. High molecular weight polysaccharides from black currant seeds inhibit adhesion of Helicobacter pylori to human gastric mucosa. Planta Med 2004 70 : 620 6.
61. Chatterjee A Yasmin T Bagchi D Stohs S. Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarythromycin. Mol Cell Biochem 2004 265 : 19 26.
62. Zhang L Ma J Pan K Go VLW Chen J You W. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter 2005 10 : 139 45.
63. Horie K Horie N Abdou AM, et al. Suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on Helicobacter pylori in humans. J Dairy Sci 2004 87 : 4073 9.
64. Di Mario F Aragona G Dal Bo N, et al. Use of bovine lactoferrin for Helicobacter pylori eradication. Dig Liver Dis 2003 35 : 706 10.
65. Ushida Y Shimokawa Y Matsumoto H Toida T Hayasawa H. Effects of bovine alpha-lactalbumin on gastric defense mechanisms in naive rats. Biosci Biotechnol Biochem 2003 67 : 577 83.
66. Brody EP. Biological activities of bovine glycomacropeptide. Br J Nutr 2000 84 Suppl. 1 S39 46.